REFERENCIAS BIBLIOHEMEROGRÁFICAS

Ginecología

Ayhan A, et al. 1994. Granulosa cell tumors of the ovary: a clinicopathological evaluation of 60 cases. Eur J Gynaecol Oncol; 15: 320.

Berek J.S, et al. 1983. Survival of patiens following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol; 61: 189.

Burke T.W, Tortolero-Luna, Baker V.V, Whittaker L, Johnson F, Mitchell M. 1996. Endometrial hiperplasia and endometrial cancer. Obstetrics & Gynecology Clinics of North America, 23(2): 411-456.

Corn B.W. 1996. Intermediate-risk endometrial cancer. A management approach. Am J Clin Oncol; 19:631-5

Creasman W.T, Morrow C.P, Bundy B.N, et al. 1987. Surgical pathologyc spread patterns of endometrial cancer. Gynecology Oncology Group Study. Cancer, 60:2035.

Culine S, Lhomme C, Michel G, et al. 1996. Is there a role for second-look laparatomy in the management of malignant germ cell tumors of the ovary? Experience at the Gustave Roussy. J Surg Oncol; 62: 40-45.

Chao C.K.S, Grigsby W.P, Perez A.C, et al. 1996. Medically inoperable Stage Y Endometrial carcinoma. Int. J. Radium Oncol Biol Phys.;34:27-31.

Di Saia J.P, Creasman T.W. 1994. Adenocarcinoma del utero. Oncología Ginecológica Clínica. 4^th edition. Mosby/Doyma.

Fanning J, Evans M.C, Peters A.J, et al. 1989. Endometrial adenocarcinoma histologic Subtypes: Clinical and pathologic profile. Ginecology Oncology, 32: 288.

Fetters M.D, Fischer G. 1996. Effectiveness of vaginal Papanicolaou smear screening after total hysterectomy for beningn disease. JAMA; 275:940-7.

FIGO. 1989. Corpus cancer staging. Int. J Gynecol Obstet, 28: 190. Spiessl B, Beahrs O.H, Hermaneck P, Hutter R.V.P, Scheibe O, Sobin L.H. Atlas TNM. Ilustrate guide to the TNM classification of malignant tumors pp. 36-40.

Greven K, Olds W. 1987. Radiotherapy in the management of endometrial carcinoma with cervical involvement. Cancer, 60:1737.

Kauppila A. 1989. Estrogen and progestin receptors as prognostic indicators In endometrial cancer: A review of the literature. Acta Oncol, 28: 561.

Kim Y.B, Holschneider C.H, Ghosh K, Nieberg R.K, Montz. 1997. Progestin alone as primary treatment of Endometrial carcinoma in premenopausal Women. Cancer, 79(2): 320-327.

Kim, R.Y. 1998. Cap. 7. Tratamiento del Cáncer de cérvix recurrente y avanzado a nivel local. En Oncología Ginecologica. Shingleton H.M. y col. McGraw Hill Interamericana.

MacMahon B. 1997. Overview of estudies on endometrial cancer and other types of cancer In humans: perspectives of an epiodemiologist. Seminars in Oncology, vol 24 (supp 1): S1-122-139.

Martinez R, Schay M, Podratz K, et al. 1989. Postoperative whole Abdomino-pelvic irradiation for patients with high risk endometrial cancer Int J Radiat Oncol Biol Phys, 17: 371.

Mc Lellan R, Dilon M.B, Currie J.L, Rosenshein.N.B. 1989. Peritoneal citology In endometrial cancer: A review. Obstet Gynecol Surv., 44:711.

Morgan R.W. 1997. Risk of endometrial cancer after tamoxifen treatment. Oncology, Vol. 11 (supp 1): 25-33.

Morley G.W, Hopkins M.P, Lindenauer S.M, Roberts J.A. 1989. Pelvic Exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol, 74: 934.

Morris M, Alvarez D.R, Kinnew K.W, et al. 1996. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol, 60:288-291.

Morrow C.P, Bundy B.N, Kumar R.J, et al. 1991. Relationship between surgical- patological risk factors and outcome in clinical stages I and II carcinoma Of endometrium. Ginecology Oncology Gropu Study. Gynecol Oncol, 40:55.

National Institutes of health consensus development conference statement. 1994. Ovarian cancer: screening, treatment and follow-up. April 5-7, Gynecol Oncol; 55: S4.

Omura G.A, et al. 1991. Long term follow-up and prognostic factor analysis in advanced ovarian carcinomas: The Gynecologic Oncology Group experience. J Clin Oncol; 9: 1138.

Piver M.S, Hempling R.E. 1990. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasión and pelvic radiation therapy for grade 3 or deep myometrial invasión in- surgical Stage I endometrial adenocarcinoma. Cancer,66:1133

Piver M.S, Lele S.B, Barlow J.J, et al. 1992. Para-aortic lymph node evaluation in stage I Endometrial carcinoma. Obstet Ginecol, 59:97.

Potish R.A, Twigss L.B, Adkock L.L, et al. 1985. Para-aortic lymph node Radiotherapy in cancer of the uterine corpus. Obstet Gynecol, 654: 251.

Poulsen H.K, Jacobsen K, et al. 1994. Adjuvant radication therapy is not necessary in the management of endometrial carcinoma. Obstet Gynecol, 84:12.

Reddoch M.J, Burke W.T, Morris M, et al. 1995. Surveillance for recurrence endometrial carcinoma. Gynecol Oncol; 59:221-225.

Rose P.G. 1996. Endometrial Carcinoma. New Engl J Med, 335:640-649.

Rose P.G, Sommers R.M, Reale F.R, et al. 1994. Serial CA 125 measurement For evaluation of recurrence in patients with endometrial carcinoma. Obstet Ginecol, 84:12.

Scully R.E, et al. Tumors of the ovary and maldeveloped gonads. Atlas of tumor pathology. 3rd Series. Washington, D. C.

Solorza Luna G, et al. 1997. Primer consenso Nacional para el diagnóstico y tratamiento de las neoplasias ginecológicas. Sociedad Mexicana de Estudios Oncológicos. México.

Shingleton H.M. 1998. Oncología Ginecológica. ed. McGraw Hill Interamericana.

Sutton G.P. 1990. The significance of positive peritoneal citology in endometrial Cancer. Oncology, 4:21.

Torres L.A, Roman B.E, Hedz A.D, y cols. 1998. Carcinoma del endometrio causas de fracaso terapéutico en 69 pacientes. Cir y Cir, 66:49-54.

Wilson T.O, Podratz K.C, Gaffey T.A, et al. 1990. Evaluation of unfavorable Histologic subtypes in endometrial adenocarcinoma. Am Journal Obstet Oncol, 162: 418.

Williams S, et al. 1994. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposido and bleomycin: a trial of the gynecologic oncology group. J Clin Oncol, 12: 701.

Williams S.D, Blessing J.A, Di Sala P.J, et al. 1994. Second look Iaparotomy in ovarian germ cell tumors:The gynecologic oncology group experience. Gynecol Oncol; 52:287-291.

Young R.C, et al. 1990. Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomizaed trials. N Engl J Med; 322:1021.

Sarcomas

Ariel I.M. 1988. Incidence of metastases to lymph node soft-tissue sarcomas. Serminars in Surgical Oncology, 4,27-29.

Bramwell V, Rouesse J, Stewart W, Santoro A, Schraffordt-Koops H, Buesa J, Rka W, Plario J, Wagener T, Burgers M, Van Unnlk J, Contesso G, Thomas D, Van Glabbeke M, Markham D, Pineda H. 1994. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma. Reduced local recurrence btit no improvement in survival: A study of the European Organization for Rescarch and Treatment Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol;12:1137-1149.

Brennan M.F, Casper E.S, Harrison L.B. 1997. Soft tissue Sarcoma In: De Vita V.T, Hellman S, Rosenberg S, eds. cancer. Principles and Practice of Oncology, 5ª ed. Lippincott Raven, Philadelphia.

Brennan M.F, Casper E.S, Harrison L.B. 1997. Soft tissue Sarcoma In De Vita V.T, Hellman S, Rosenberg S, eds.cancer.Principles and of Oncology, 5^th edition. Philadelphia PA:Lippincott Raven,:1738.

Pisters P, Leung D, Woodruff J, Shi W, Brenan M. 1996. Analysis of prognostic factors In 1,041 patients with localized soft tissue sarcomas of the extremitles. J.Clin Oncol; 14.1679.

Gaynor J, Tan C, Casper E, et al. 1992. Refinement of clinicopathologic staging for localizad soft tissues sarcoma of the extremity: A study of 423 adults. J Clin Oncol;1317-29.

Chang A.E, Kinsella T, Glatstein E, Baker A.R, Sindelar W.F, Lotze M.T, Danforth J.R, D.N, Sugarbaker P.H, Lack E.E, Steinberg S.M, Whlte D.E, Rosemberg S.A. 1988. Adjuvant chemotherapy for patients wlth high-grade soft-tissue sarcomas of the extremity. J Clin Oncol; 6:1491-1500.

Edmonson J.H, Fleming T.R, Invlns J.C, E.O, Soule E.H, O’Connel M.J, Sim F.H, Ahmann D.L. 1984. Randomized study of systemic chemoterapy followng complete excisión of nonosseous sarcomas. J Clin Oncol; 2:1390-6.

Geer R.J, Woodruff J, Caspers E.S, Brennan M.F. 1992. Management of small soft tissue sarcoma of the extremity in adults. Arch Surg;127:1285.

Huvos A.G. 1991. Bone Tumors. Diagnosis, treatment and prognosis. 2^nd. W.B. Saunders Company, Philadelphla, Pa.

Roth J. 1985. Differing determinants of prognosis following resection of pulmonary m etastases from osteogenic and soft tissue sarcoma patients. Cancer, 55, 1361–1366.

Pisters P, Harrison L.B, Leung D.H, et al. 1996. Long-Trem results of a prospective randomized trial of adjuvant brachyterapy in soft tissue sarcoma. J Clin Oncol;14:859.

Vezeridis M, et al. 1983. Metastatic patterns in soft-tissue sarcomas. Arch. Surg. 118, 915-918.

Digestivo

Arnold R. 1994. Managment of gastroenteropancreatic endocrine tumors; the place of somation analoges. Digestion; 55:107.

Ballantyne G.H. 1992. Incide and mortality of carcinoids of the colon. Cancer; 69:2400-5.

Cameron A.J, Ott B.J, Payne W.S. 1985. The incidence of adenocarcinoma in columnar-tined (Barrets) New Engl J Med. 313 :857-859.

Creutzfeld W. 1996. Carcinoid tumors: development of our Knowledge. Word J Surg. 20:126-31.

Eller R.F. 1997. Gastrointestinal carcinoid tumors. Am J Surg; 57:434-7.

Carter D.C. 1980. Surgey for Pancreatic Cancer. Br.Med J;1-744-746.

Cello J.P, Gestenberger P.D, Wright T, et al. 1985. Endoscopic neodynium-YAG láser palliation of non reesectable esophageal malignancy. Ann Intem Med; 102:610-612.

Feldemar J.M. 1989. Carcinoid tumors and the carcinoid syndrome. Cur Probl Surg; 28:835.

Irvin M.M. 1997. An analysis of 8305 cases of carcinoid tumor. Cancer; 79:813.

Lelchman L, Herskovic A, Llechman C.G, et al. 1987. Nonoperative Therapy for squamous-cell cancer of the esophagus. J.Clin Oncol; 5 365-370.

Matuchansky C. 1995. Serotoin catecholamines and spotaneus midgut carcinoid flush. Plasma studies from fhusing and no flushing sities. Gastroenterol;108:743.

Paul C.N. 1997. Carcinoid disearse. Dis Colon Rectum;40:349-62.

Melanoma

Breslow A. 1970. Thickness, cross-sectional areas and depth of melanoma in the prognosis of cutaneous melanoma. Ann Surg; 72:902.

Kirkwood J.M, et al. 1996. Interferon alfa 2b adjuvant therapy of high-risk resected cutaneous melanoma: The eastern cooperative oncology group trial for high-risk melanoma. J Oncol; 14:1

Medina J.E. Canfield V. 1996. Malignant Melanoma of the head neck. p 174 en Myers, Suen, eds. Cancer of the head neck, 3^rd ed.

Libros

Ackermans. 1996. Surgical Pathology. Mosby.

American Cancer Society. 1995. Texbook of clinical Oncology. Second edition.

American Joint Comite for Cáncer. ed. 1998. Manual of Staging of Cáncer, 4ª Philadelphia, JB Lippincott.

Balch M.C, Houghton A.N, Milton G.W, Soong S, Sober A.J. eds. 1992. Cutaneous melanoma, 2^nd edition Philadelphia PA. JB Lippincott.

Berchuck A, Anspach C, Evans C.A, Sobert J. et al. 1995. Postsurgical surveillance of patiens with FIGO stage I-II Endometrial adenocarcinoma. Gynecol. Oncol. 59:20-24.

Bereck J.S, Nevelli F.H. eds. 1992. Practical Gynecology Oncology Williams & Wilkins 1989. Barber, H.R.K. ed. Oncologica ginecologica, 2^nd edition, México McGraw-Hill Interamericana.

Burghardt E. 1993. Surgical Gynecologic Oncology. Thieme Medical Publishers.

De Vita Vincent, Hellman Samuel, Rosenberg Steven. 1997. Cancer: Principles & Practice of Oncology. 5^th edition. Philadelphia Pa. Lippincott-Raven.

Donegan W.L. Primary treatment and end results in cancer of the breast. Donegan Sprat J.S. 2^nd ed. Editorial WB. Sanders Piladelphia .

Gordis Lgold E.B. 1988. Epiderniology and Etiology of Pancreatic Cancer In: Go V.L.W, Brooks F.P, DiMagno E.P, et al. eds. The Exocrine Pancreas: Biology Pathobiology and Diseases. New York. Raven press

Hermanek P, Gospodarowiccz M.K, Henson D.E, Hutter R.V.P, Sobin L.H. 1995. Prognostic factors in cancer. Berlin: Eds. Springer–Verlag.

Hoskins W.J. Ed. 1992. Principles and practice of gynecologic oncology. Philadelphia: JP. Lippincott.

Million R.R. 1995. Management of Head and Nek Cancer. 2ª ed.

Myers N.E, Suen J. 1996. Cancer of the Head & Neck. 3^rd edition. W B Saunders.

Myers E.N, Johnson J.T, Curtin H.D. eds. 1996. Cancer of the Head and Neck. WB Saunders Co.Philadelphia Pa.

Schiff L, Schiff E.R. eds. 1987. Diseases of the Liver. 6^th ed. Phyladelphia: J.B. Lippincott Co. 1109-1158.

Schwartz, S, et al. 1995. Principios de Cirugía. 6 ed. México, Ed. McGraw-Hill- Nueva Editorial Interamericana.

Hoskins W.J, Pérez C.A, Young eds. Principles & Practice of Gynecology. J.B Lippincott, 1992.

Mama

Diel I.J, et al. 1998. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med;339:357-363.

Cárdenas Sánchez J. Aceves Escárcega A, Sánchez Forgach E. 1995. Consenso Nacional sobre el tratamiento del cáncer mamario Rev. Inst.Nal. Cancerol. México. 41, 136-145.

Carlomagno C, et al. 1996. CerbB overexpression decreaces the benefit of adjuvant Tamoxifen in early-stage breast cancer without axillary lymph node metástasis. J Clin Oncol;14:2702-2708.

Fisher E.R, Osborne, McGuire W.L, et al. 1981. Correlation of primary breast cancer histopathology and estrogen receptor cotent, Breast Cancer Res Treat. 1:37-41.

Fornader T, Cedermark B, Mattson A, et al. 1989. Adjuvant Tamoxifen in early breast cancer: Ocurrence of new primary cancers. Lancet; 1:117-120.

Greenderg P.A.C, Hortobagyi G.N, et al. 1996. Long-term follow-up patients with complete remission following combination chemotherapy for metastasic breast cancer. J clin Oncol; 14:2197-2205.

Garden A.S. 1989. Postoperative radiotherapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer, 73:2563-69.

Mauridaen H, Palshof T, Patterson J, et al. 1978. Tamoxifen in avanced breast cancer. Cancer treat rev. 5:131-141.

Pick P.W, Lossifides A. 1984. Ocurrence of breast carcinoma within a fibroadenoma. Arch Pathol Lab Med. 108:590-594.

Winchester D.P. 1996. Breast Cancer in young Women. Surg Clin N Am; 76:279-287.

Urología

Catalona W.J, Smith D.S. 1994. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol, 152;1837-42.

Chodak G.W. 1994. Results of conservative managment of clinically localized prostate cancer. N Engl J Med;330:242-248.

Coogan C.L, Foster R.S, Simmons G.R, et al. 1998. Bilateral Testicular: Management and Outcome in 21 Patients Cancer 83(3):54-52.

Dreise R, Cooper C, Williams R. 1996. Tratamiento del cáncer de próstata y de vejiga urinaria en el anciano. Clínicas de Urología de Norteamérica.

Gomes P.J, Rustin G.J. 1996. Attempted preservation of one gonad in patiens with bilateral germ cell tumors. Clin Oncol; 8:397-399.

Haggman M.J, Macoska J.A. 1997. The relationship betwen prostatic intraephitelial neoplasia and prostate cancer critical issues. J Urol; 158:12-22.

Cabeza y Cuello

Armstrong J.G. 1992. The indications for elective treatment of the neck in cancer of the major salivary tumors. Cancer,-69:615-19.

Champy. Cols. 1978. Mandibular osteosintesis by miniature screwed plates via bucal aproach J Max Fac Surg. 6,243.

McKeena. 1984. Tumors of the major and minor salivary glands. Cancer; 59:887.

Medina J.E, Byers R.M. 1989. Supraomohioid neck dissection: Rationale, indications, and surgical technique.Head Neck; 11:1-22.

Medina J.E. 1989. A rational classification of neck dissections. Otolaryngol Head and Neck Surg. 100: 169-176.

Netterville J.L, Reiiiy K.M, Robertson D, et al. 1995. Carotid body tumors: A review of 30 patients with 46 tumors. Laryngoscope 105:115-126.

Patrick A, Treseler M.D. 1997. Prognostic factors in thyroid carcinoma. Surgical Clinics of North America. Vol. 6 Number 3. July, pp. 584-590.

Spiro R. 1986. Salivary neoplasms: overview of 25 years experience With 2, 807 patients. Head Neck surg;8:177.

Misceláneos

Biggs J.C, et al. 1992. Treatment for chronic myelogenus leukemia with allogeneic bone marrow transplantation following preparation with BU-Cy2. Blood, 80, 1352-7.

Breslow N.E, Langholz B. 1983. Childhood cancer incidence: Geographical and temporal variations. Int J Cancer 32:703-716.

Brochstein J, et al. 1987. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Eng J Med. 317:1618.

Kramer S, Meadows A.T, Jarrett P, Evans A.E. 1983. Incidence of chilhood cancer: Experience of a decade in a population-based registry. J Natl Cancer Inst. 70:49-55.

Mountain C.F. 1997. Revision of the international. System for lung cancer. Chest 111 (6);1711:1717.

Rubin S.C. 1998. Chemoprevention of hereditary cancer. N Engl J Med; 339:469-471.

SSA. 1996. Registro Histopatológico de neoplasias en México. Epidemiología.

 Wadler S, et al. 1998. Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol; 16:3169-3178.

Young J.L, Miller R.W. 1975. Incidence of malignant tumors in U.S. children. J Pediatr. 86:254-258.